Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honghong Zou

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Cardiology|February 18, 2018
Corrigendum to "The prevention of statins against AKI and mortality following cardiac surgery: A meta-analysis" [Int. J. Cardiol. 222 (Nov 1 2016) 260-6]Minxiong Li, Honghong Zou, Gaosi Xu
Internal Medicine Journal|August 8, 2019
Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathyHonghong Zou, Fang Jiang, Gaosi Xu
Cardiovascular Diabetology|March 11, 2018
Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney diseaseHonghong Zou, Baoqin Zhou, Gaosi Xu
Kidney & Blood Pressure Research|November 28, 2016
Clinical Utility of Serum Cystatin C in Predicting Diabetic Nephropathy Among Patients with Diabetes Mellitus: a Meta-AnalysisBaoqin Zhou, Honghong Zou, Gaosi Xu
International Journal of Cardiology|August 7, 2016
The prevention of statins against AKI and mortality following cardiac surgery: A meta-analysisMinxiong Li, Honghong Zou, Gaosi Xu
Critical Care (London, England)|June 19, 2017
Early versus late initiation of renal replacement therapy impacts mortality in patients with acute kidney injury post cardiac surgery: a meta-analysisHonghong Zou, Qianwen Hong, Gaosi Xu
BMC Nephrology|December 4, 2019
Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathyHonghong Zou, Yebei Li, Gaosi Xu
Cardiovascular Diabetology|May 18, 2017
SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney diseaseHonghong Zou, Baoqin Zhou, Gaosi Xu
Critical Care (London, England)|April 27, 2019
Correction to: Early versus late initiation of renal replacement therapy impacts mortality in patients with acute kidney injury post cardiac surgery: a meta-analysisHonghong Zou, Qianwen Hong, Gaosi Xu
Renal Failure|July 30, 2019
Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathyHonghong Zou, Fang Jiang, Gaosi Xu
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Cardiology|February 18, 2018
Corrigendum to "The prevention of statins against AKI and mortality following cardiac surgery: A meta-analysis" [Int. J. Cardiol. 222 (Nov 1 2016) 260-6]Minxiong Li, Honghong Zou, Gaosi Xu
Internal Medicine Journal|August 8, 2019
Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathyHonghong Zou, Fang Jiang, Gaosi Xu
Cardiovascular Diabetology|March 11, 2018
Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney diseaseHonghong Zou, Baoqin Zhou, Gaosi Xu
Kidney & Blood Pressure Research|November 28, 2016
Clinical Utility of Serum Cystatin C in Predicting Diabetic Nephropathy Among Patients with Diabetes Mellitus: a Meta-AnalysisBaoqin Zhou, Honghong Zou, Gaosi Xu
International Journal of Cardiology|August 7, 2016
The prevention of statins against AKI and mortality following cardiac surgery: A meta-analysisMinxiong Li, Honghong Zou, Gaosi Xu
Critical Care (London, England)|June 19, 2017
Early versus late initiation of renal replacement therapy impacts mortality in patients with acute kidney injury post cardiac surgery: a meta-analysisHonghong Zou, Qianwen Hong, Gaosi Xu
BMC Nephrology|December 4, 2019
Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathyHonghong Zou, Yebei Li, Gaosi Xu
Cardiovascular Diabetology|May 18, 2017
SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney diseaseHonghong Zou, Baoqin Zhou, Gaosi Xu
Critical Care (London, England)|April 27, 2019
Correction to: Early versus late initiation of renal replacement therapy impacts mortality in patients with acute kidney injury post cardiac surgery: a meta-analysisHonghong Zou, Qianwen Hong, Gaosi Xu
Renal Failure|July 30, 2019
Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathyHonghong Zou, Fang Jiang, Gaosi Xu
Pageof 3